Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-12

FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Mylan Pharmaceuticals' supplemental application for Amnesteem (isotretinoin), a generic version of isotretinoin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMNESTEEM (isotretinoin)

Snippet

SUPPL AP for AMNESTEEM (ISOTRETINOIN)